Malignant Neoplasm Clinical Trials in Beijing, Beijing Municipality
10 recruitingBeijing, Beijing Municipality, China
Showing 1–10 of 10 trials
Recruiting
Phase 1
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Metastatic Breast CancerHER2-negative Breast CancerAdvanced Solid Tumor+6 more
BeOne Medicines399 enrolled63 locationsNCT06120283
Recruiting
Phase 1
A Study of DEG6498 in Participants With Solid Tumors
Malignant Neoplasms
Degron Therapeutics Co.100 enrolled2 locationsNCT07244835
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
Advanced Solid TumorsMalignant Neoplasm
Merck Sharp & Dohme LLC270 enrolled45 locationsNCT06818643
Recruiting
Phase 1Phase 2
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Malignant Neoplasm
Tyligand Pharmaceuticals (Suzhou) Limited440 enrolled19 locationsNCT06385925
Recruiting
Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors
Non-small Cell Lung CancerPET/CTMalignant Neoplasm+1 more
Peking University People's Hospital80 enrolled1 locationNCT07487883
Recruiting
Not Applicable
Application of the CD73-Targeted Probe ⁶⁸Ga-DOTA-mPNE PET/CT Imaging in the Diagnosis of Malignant Tumors
Malignant Neoplasms of Brain
Peking Union Medical College Hospital50 enrolled1 locationNCT07023640
Recruiting
Phase 1
NV-001 in the Treatment of Advanced Solid Tumors
Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences20 enrolled1 locationNCT06051760
Recruiting
Phase 1Phase 2
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
Advanced Malignant NeoplasmAdvanced or Metastatic Non-small Cell Lung Cancer
SUNHO（China）BioPharmaceutical CO., Ltd.78 enrolled1 locationNCT06581419
Recruiting
Phase 1
TSN084 Treating Patients With Advanced Malignant Tumors
Malignant Neoplasm
Tyligand Bioscience (Shanghai) Limited114 enrolled2 locationsNCT06386705
Recruiting
Early Phase 1
Clinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy
Advanced Malignant Neoplasm
Peking University Cancer Hospital & Institute10 enrolled1 locationNCT05985278